Back to results
US 2008/0103176 A1Published application
Substituted Hydroxyethylamines
AssigneePfizer Inc.
InventorsBrian Bronk, Todd Butler
Life of this patent
Estimating the term…
Abstract
This invention is directed to compounds of the formula (I), as defined herein. The compound of formula I may be used, for example, to treat a disorder or condition that may be treated by inhibiting 13-secretase.
Claims14
A compound of the formula I
- wherein
- W is selected from the group consisting of (i) C6-C10 aryl optionally substituted with one to three substituents each independently selected from H, halogen, CN, NO2, OH, O—C1-C8 alkyl, NH2, NH—C1-C8alkyl, N(C1-C8alkyl)2, NHCO—C1-C8alkyl, and CONH—C1-C8alkyl, and (ii) C5-C10 heteroaryl optionally substituted with one to three substituents each independently selected from H, halogen, CN, NO2, OH, O—C1-C8 alkyl, NH2, NH—C1-C8 alkyl, N(C1-C8 alkyl)2, NHCO—C1-C8 alkyl, and CONH—C1-C8 alkyl,
- R1 is C1-C6 alkyl, optionally substituted with up to three fluoro atoms;
- R5 and R6 are each independently selected from the group consisting of H, C1-C8 alkyl, C2-C8 alkenyl, C3-C8 alkynyl, C3-C5 cycloalkyl, 5-10 membered heteroaryl, and C6-C14 aryl;
- p is from 0 to 1,
- represents a single or double bond, with the proviso that if is a double bond, X is N, C(C1-C6 alkyl), or O, with the proviso that if X is O and p is 1, R10 is absent;
- and with the proviso that if is a single bond, X is C0-C6 alkylene, C(═C1-C6 alkylidene), C(—N—O—C1-C6 alkyl), C(═N—C1-C6 alkyl), C═O, NH, NC1-C6 alkyl, or O;
- and
- R10 is selected from the group consisting of H, C1-C6 alkyl, —OH, —O—C1-C6 alkyl, —CO—C1-C6 alkyl, —COO—C1-C6 alkyl, —NH—C1-C6 alkyl, —N(C1-C6 alkyl)-C1-C6 alkyl, —CO—N(C1-C6 alkyl)-C1-C6 alkyl, 5-10 membered heteroaryl, 5-10-membered heterocycloalkyl, C6-C14 aryl, S(O)qC1-C6 alkyl, and S(O)qC6-C10 aryl.
6 more elements
The compound of claim 8 wherein R2 is fluoro.
The compound of claim 13, wherein the compound is the optical isomer Iaa.
Dependencies are inferred from the claim text.